Ramucirumab (RAM) as second-line treatment in patients (pts) with advanced hepatocellular carcinoma (HCC): Prognosis, efficacy, and safety by liver disease etiology
Okusaka, T.; Blanc, J.-F.; Chau, I.; Yang, L.; Abada, P.; Zhu, A.X.
- 期刊名称Annals of Oncology
- 作者Okusaka, T.; Blanc, J.-F.; Chau, I.; Yang, L.; Abada, P.; Zhu, A.X.
- 卷第27卷
- 印刷ISSN0923-7534
- 电子ISSN1569-8041
- 文件大小39.83KB
- 发表时间2016-10-01
- DOI10.1093/annonc/mdw371.09